Inari Historical Financial Ratios
| NARI Stock | USD 51.92 0.89 1.74% |
Inari Medical is lately reporting on over 101 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 80.03 will help investors to properly organize and evaluate Inari Medical financial condition quickly.
Inari |
About Inari Financial Ratios Analysis
Inari MedicalFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Inari Medical investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Inari financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Inari Medical history.
Inari Medical Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Inari Medical stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Inari Medical sales, a figure that is much harder to manipulate than other Inari Medical multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Free Cash Flow Yield
A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.Ev To Free Cash Flow
A valuation metric comparing the company's enterprise value to its free cash flow, used to evaluate whether a company is undervalued or overvalued.Most ratios from Inari Medical's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Inari Medical current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Inari Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.As of now, Inari Medical's Free Cash Flow Yield is increasing as compared to previous years. The Inari Medical's current Operating Cash Flow Per Share is estimated to increase to 0.66, while Price To Sales Ratio is projected to decrease to 7.09.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 3.78 | 5.81 | 5.58 | 3.14 | Days Of Inventory On Hand | 310.39 | 267.2 | 265.09 | 310.46 |
Inari Medical fundamentals Correlations
Click cells to compare fundamentals
Inari Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Inari Medical fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 40.06 | 20.02 | 16.42 | 8.76 | 7.47 | 7.09 | |
| Ptb Ratio | (52.32) | 13.96 | 19.01 | 8.05 | 7.93 | 8.32 | |
| Days Sales Outstanding | 80.68 | 73.19 | 55.81 | 55.79 | 51.85 | 80.03 | |
| Book Value Per Share | (0.81) | 6.25 | 4.8 | 7.89 | 8.19 | 8.6 | |
| Free Cash Flow Yield | (0.003945) | (0.001269) | 0.002604 | (0.007123) | 0.008066 | 0.008469 | |
| Operating Cash Flow Per Share | (0.1) | 0.0597 | 0.51 | (0.26) | 0.63 | 0.66 | |
| Stock Based Compensation To Revenue | 0.009873 | 0.0252 | 0.0919 | 0.0748 | 0.0817 | 0.0426 | |
| Capex To Depreciation | 5.12 | 3.94 | 3.17 | 1.4 | 0.58 | 0.55 | |
| Pb Ratio | (52.32) | 13.96 | 19.01 | 8.05 | 7.93 | 8.32 | |
| Ev To Sales | 39.98 | 19.2 | 16.19 | 8.68 | 7.45 | 7.08 | |
| Free Cash Flow Per Share | (0.17) | (0.11) | 0.24 | (0.45) | 0.52 | 0.55 | |
| Roic | (0.0652) | 0.0981 | 0.0256 | (0.0751) | 0.0116 | 0.011 | |
| Inventory Turnover | 1.5 | 1.24 | 1.18 | 1.37 | 1.38 | 1.04 | |
| Net Income Per Share | (0.0396) | 0.43 | 0.2 | (0.55) | (0.0288) | (0.0303) | |
| Days Of Inventory On Hand | 244.13 | 295.12 | 310.39 | 267.2 | 265.09 | 310.46 | |
| Payables Turnover | 2.32 | 4.3 | 3.78 | 5.81 | 5.58 | 3.14 | |
| Sales General And Administrative To Revenue | 0.73 | 0.64 | 0.69 | 0.76 | 0.71 | 0.94 | |
| Capex To Revenue | 0.0615 | 0.0391 | 0.0493 | 0.0259 | 0.0126 | 0.0119 | |
| Pocfratio | (414.95) | 1.5K | 178.4 | (240.36) | 102.58 | 121.69 | |
| Interest Coverage | 0.87 | 16.23 | 22.62 | (95.57) | (71.59) | (68.01) | |
| Capex To Operating Cash Flow | (0.64) | 2.86 | 0.54 | (0.71) | 0.17 | 0.16 | |
| Pfcf Ratio | (253.48) | (788.12) | 383.98 | (140.38) | 123.98 | 130.18 | |
| Days Payables Outstanding | 157.41 | 84.86 | 96.44 | 62.81 | 65.36 | 122.89 | |
| Income Quality | 4.14 | 0.14 | 2.59 | 0.48 | (21.96) | (20.86) | |
| Roe | 0.0487 | 0.0689 | 0.0411 | (0.0702) | (0.003519) | (0.003343) | |
| Ev To Operating Cash Flow | (414.11) | 1.4K | 175.91 | (238.36) | 102.4 | 113.9 | |
| Pe Ratio | (1.1K) | 202.79 | 462.06 | (114.75) | (2.3K) | (2.1K) | |
| Return On Tangible Assets | (0.0428) | 0.0644 | 0.0316 | (0.0581) | (0.005294) | (0.005559) | |
| Ev To Free Cash Flow | (252.97) | (755.92) | 378.61 | (139.21) | 123.76 | 129.95 | |
| Earnings Yield | (9.31E-4) | 0.004931 | 0.002164 | (0.008715) | (4.44E-4) | (4.66E-4) | |
| Net Debt To E B I T D A | (11.61) | (6.96) | (4.1) | 1.53 | (0.43) | (0.45) | |
| Current Ratio | 4.44 | 14.86 | 5.77 | 7.53 | 3.09 | 2.93 | |
| Tangible Book Value Per Share | (0.81) | 6.25 | 4.8 | 7.89 | 1.76 | 2.54 | |
| Graham Number | 0.85 | 7.78 | 4.62 | 9.92 | 2.3 | 3.68 | |
| Shareholders Equity Per Share | (0.81) | 6.25 | 4.8 | 7.89 | 8.19 | 8.6 |
Currently Active Assets on Macroaxis
When determining whether Inari Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inari Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inari Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inari Medical Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Inari Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inari Medical. If investors know Inari will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inari Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.84) | Earnings Share (1.35) | Revenue Per Share 9.901 | Quarterly Revenue Growth 0.214 | Return On Assets (0.03) |
The market value of Inari Medical is measured differently than its book value, which is the value of Inari that is recorded on the company's balance sheet. Investors also form their own opinion of Inari Medical's value that differs from its market value or its book value, called intrinsic value, which is Inari Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inari Medical's market value can be influenced by many factors that don't directly affect Inari Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inari Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inari Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inari Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.